Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine enhanced DC-CIK for malignant solid tumors
NCT04292769Phase 3Unknown
- Start
- Jan 2020
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of decitabine in malignant solid tumor. Status: unknown.
02
Drugs
decitabine
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT04292769.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04292769.